You just read:

FDA Approves HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]), First and Only Subcutaneous Preventive Treatment for Hereditary Angioedema

News provided by

CSL Behring

Jun 23, 2017, 14:16 ET